Depo Shots Lawsuit 2026: Payouts and How to File

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

The depo shots lawsuit is one of the biggest pharmaceutical cases moving through the courts in 2026. Thousands of women who received Depo-Provera birth control injections are filing claims after research linked the drug to meningioma brain tumors.

If you used this contraceptive and developed a brain tumor, you may be entitled to significant compensation. Studies suggest the risk of meningioma increases by up to 5.6 times with prolonged use.

Worth reading: Education Lawsuit Last Week: 2026 Payout and Filing Guide

This article breaks down everything you need to know. You’ll find 2026 lawsuit updates, settlement estimates, eligibility rules, filing steps, and deadlines. We also cover the scientific evidence, what Pfizer knew, and exactly what records you need to build a strong claim.

Depo Shots Lawsuit

The depo shots lawsuit refers to legal claims filed against Pfizer by women who developed meningioma brain tumors after receiving Depo-Provera injections. These cases allege that Pfizer knew about the tumor risk but failed to adequately warn patients or doctors.

Depo-Provera is an injectable birth control containing medroxyprogesterone acetate, a synthetic progestin hormone. Millions of women in the U.S. have used it since its FDA approval in 1992.

The core allegation is straightforward. Pfizer had access to scientific data showing a connection between prolonged progestin exposure and meningioma growth. The company allegedly chose profits over patient safety.

These lawsuits are not about minor side effects. Meningiomas can require brain surgery, cause seizures, impair vision, and permanently alter quality of life.

Even when meningiomas are classified as “benign,” the treatment is anything but simple. Many women have undergone craniotomies, radiation therapy, and years of monitoring scans.

Depo Provera Lawsuit Update 2026

The Depo-Provera lawsuit is expected to reach several key milestones in 2026. The MDL is gaining momentum, with hundreds of new claims entering the consolidated proceedings.

As of early 2026, the litigation is in the discovery phase. Both sides are exchanging documents, deposing witnesses, and building their scientific arguments.

Bellwether trials are the next major event to watch. These are test cases selected from the larger pool to help both sides gauge how juries might react to the evidence.

2026 Timeline Projections:

• Q1 2026: Continued discovery and expert witness depositions
• Q2 2026: Possible selection of bellwether cases
• Q3-Q4 2026: Potential bellwether trial dates or pre-trial hearings
• Late 2026 or early 2027: Settlement talks could begin if bellwether results favor plaintiffs

The pace of the litigation depends on several factors. Court scheduling, the volume of new filings, and Pfizer’s legal strategy all play a role.

One thing is clear. The number of filed claims is increasing every month. More women are learning about the connection between Depo-Provera and meningioma, and attorneys across the country are accepting new cases.

If early bellwether trials go well for plaintiffs, Pfizer may face pressure to negotiate a global settlement. That’s the pattern we’ve seen in similar pharmaceutical mass torts.

Depo Provera Brain Tumor Lawsuit

The Depo-Provera brain tumor lawsuit centers on one core claim: this birth control shot significantly increases the risk of developing meningioma. Multiple peer-reviewed studies back up that claim.

A 2024 study published by French researchers at INSERM found that women who used injectable progestins like medroxyprogesterone acetate for more than one year had a 5.6 times higher risk of developing intracranial meningioma.

That’s not a small bump in risk. To put it in perspective, that’s roughly the same increase in lung cancer risk you’d see in a moderate smoker compared to a non-smoker.

Brain tumors diagnosed in these cases are typically meningiomas. They grow from the meninges, the membranes surrounding the brain and spinal cord.

Though often labeled “benign,” these tumors can cause debilitating symptoms. Headaches, vision loss, hearing problems, memory issues, and seizures are all common.

Many women have needed one or more surgeries to remove these tumors. Some tumors grow back after removal, requiring repeated interventions.

Key Takeaway: Scientific evidence from multiple studies shows Depo-Provera users face a dramatically higher risk of brain tumors, and the lawsuits argue Pfizer should have warned them.

Depo Provera Meningioma Lawsuit

The Depo-Provera meningioma lawsuit specifically targets the link between this injectable contraceptive and meningioma tumors. Meningioma is the most common type of brain tumor, and it’s the injury at the center of nearly every Depo-Provera claim.

Meningiomas grow slowly in most cases. That’s part of what makes them dangerous in this context. A woman could use Depo-Provera for years, and the tumor might not produce symptoms until long after she stopped the injections.

These tumors are graded on a scale of I to III:

Most Depo-Provera-related meningiomas fall into Grade I. But “benign” is misleading here. A tumor pressing against your brain can cause permanent neurological damage regardless of its grade.

Plaintiffs in these cases have reported a range of lasting injuries. Some have lost partial vision permanently. Others deal with chronic headaches and cognitive decline.

The key legal argument is that meningioma cells often contain progesterone receptors. When these receptors are exposed to high levels of synthetic progestin from Depo-Provera injections, tumor growth can be stimulated.

Pfizer allegedly knew about this receptor connection for years. Internal documents and published research available to the company are expected to play a central role in trial proceedings.

Depo Provera Settlement Amounts

Depo-Provera settlement amounts have not been officially determined yet, because no settlements have been reached as of early 2026. However, legal analysts and attorneys handling these cases have offered projected ranges based on comparable pharmaceutical mass torts.

Estimated settlement values vary widely depending on the severity of the injury. A woman who had brain surgery will likely receive far more than someone whose tumor is being monitored without intervention.

These projections are estimates, not guarantees. Actual settlement amounts will depend on bellwether trial outcomes, the strength of individual evidence, and Pfizer’s willingness to negotiate.

Several factors will influence your potential payout:

• Duration of Depo-Provera use (longer use generally means stronger claims)
• Size and location of the tumor
• Surgeries required and medical costs incurred
• Lost wages and earning capacity
• Pain, suffering, and reduced quality of life

In similar pharmaceutical mass torts, like the Zantac and talcum powder cases, settlements ranged from tens of thousands to millions of dollars per claimant. The Depo-Provera litigation could follow a similar pattern.

Who Qualifies for Depo Provera Lawsuit

You may qualify for a Depo-Provera lawsuit if you received one or more Depo-Provera injections and were later diagnosed with a meningioma brain tumor. That’s the basic threshold.

Not every person who used the drug is eligible. The connection between your Depo-Provera use and a diagnosed meningioma is what matters most.

General qualification criteria include:

• You received at least one Depo-Provera injection
• You were diagnosed with a meningioma (any grade)
• Your diagnosis came after you started using Depo-Provera
• You can provide medical records documenting both the injections and the diagnosis

Stronger claims typically involve women who used the shot for one year or longer. The French INSERM study specifically found elevated risk in women with prolonged use.

You don’t need to have had surgery to file a claim. A confirmed meningioma diagnosis is sufficient. But surgical intervention typically strengthens the case and increases potential compensation.

If you’re unsure whether you qualify, most attorneys handling these cases offer free case evaluations. There’s no cost to find out.

Key Takeaway: If you used Depo-Provera and were diagnosed with a meningioma, you likely qualify to file a claim, and longer use strengthens your case.

Depo Provera Lawsuit Eligibility

Depo-Provera lawsuit eligibility depends on a combination of medical history, timing, and documentation. Meeting the basic criteria doesn’t automatically mean your case will move forward, but it does mean you should explore your options.

There are a few factors that attorneys evaluate when screening potential cases:

• Timing: Did your meningioma diagnosis come after you began Depo-Provera use? If the tumor was diagnosed before you ever received the shot, the case is harder to make.
• Causation link: Can medical records show a plausible connection between the drug and your tumor?
• Statute of limitations: Have you filed within your state’s legal deadline? (More on this in the deadline section below.)

Some women have been using Depo-Provera for over a decade. Others used it briefly years ago. Both scenarios can still produce eligible claims, though the evidence burden differs.

Situations that typically DO qualify:

• Diagnosed with meningioma after 6+ months of Depo-Provera use
• Tumor contains progesterone receptors (confirmed by pathology)
• Medical records from both the prescribing doctor and diagnosing neurologist are available

Situations that may NOT qualify:

• Meningioma diagnosed before any Depo-Provera use
• No medical records available to document injections
• Statute of limitations has expired in your state with no discovery rule exception

The discovery rule is important here. In many states, the clock on your statute of limitations starts when you discovered (or should have discovered) the link between Depo-Provera and your tumor. Since this research is relatively new, many women may still be within their filing window.

How to File Depo Provera Lawsuit

Filing a Depo-Provera lawsuit starts with contacting an attorney who handles pharmaceutical mass tort cases. You don’t need to go to court on your own. The process is designed to be straightforward for claimants.

Here’s a step-by-step breakdown of what the filing process looks like:

Step 1: Free Case Evaluation
Contact a law firm experienced in Depo-Provera litigation. Most offer no-cost consultations. You’ll share your medical history and Depo-Provera usage details.

Step 2: Gather Medical Records
Your attorney will help you collect records showing your Depo-Provera injections and meningioma diagnosis. This includes pharmacy records, doctor visit notes, MRI results, and surgical reports.

Step 3: Attorney Signs You Up
If your case meets the criteria, you’ll sign a retainer agreement. Most Depo-Provera attorneys work on contingency. You pay nothing upfront and they take a percentage only if you win.

Step 4: Case Filed in Court
Your attorney files your complaint, which is then transferred into the MDL if applicable. From there, your case joins the consolidated litigation.

Step 5: Wait for Litigation Progress
Once filed, your individual case moves with the larger MDL. You may be asked to provide depositions or additional records, but your attorney handles most of the legwork.

The entire process from first call to filing typically takes 4 to 8 weeks. The waiting for resolution takes much longer, often years.

Depo Provera Class Action Lawsuit

The Depo-Provera class action lawsuit is actually a common misconception. As of 2026, the Depo-Provera litigation is structured as a multidistrict litigation (MDL), not a traditional class action.

The difference matters. In a class action, one or a few plaintiffs represent an entire group, and everyone gets the same outcome. In an MDL, each plaintiff has their own individual case, but the cases are grouped together for efficiency during pre-trial proceedings.

Before you go further, consider reading Shocking Entertainment Lawsuit 2026: Claims and Payouts

This distinction is good news for plaintiffs. It means your compensation will be based on your specific injuries, not an average payout divided among thousands of people.

Think of it like this. A class action is like splitting one pizza among 10,000 people. An MDL is more like each person ordering their own meal based on what they need.

The MDL is centralized in federal court to streamline discovery and pre-trial motions. But if the case goes to trial, it would be tried individually or in small groups (bellwether trials).

Key Takeaway: Depo-Provera cases are handled as individual claims within an MDL, not a class action, which means your payout will be based on your specific injuries and medical history.

Depo Provera MDL Update

The Depo-Provera MDL is the central hub for all federal Depo-Provera brain tumor lawsuits. As of 2026, the case count continues to climb, and the litigation is progressing through the discovery phase.

The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated these cases to streamline proceedings. All federal Depo-Provera meningioma claims are being handled together rather than in scattered courthouses across the country.

Current MDL Status (Early 2026):

• Discovery is ongoing, with both sides exchanging scientific evidence and internal corporate documents
• Expert witnesses are being deposed, including oncologists, epidemiologists, and pharmaceutical researchers
• Plaintiff case fact sheets are being collected to categorize individual claims
• A leadership structure of plaintiff attorneys has been appointed to manage the litigation

What to expect for the rest of 2026:

• Selection of bellwether trial cases (likely mid-2026)
• Daubert hearings to determine which expert testimony is admissible
• Possible first bellwether trial scheduled for late 2026 or early 2027
• Continued increase in filed claims as public awareness grows

The bellwether process is worth watching closely. These test trials give both sides a preview of how juries react to the evidence. Strong plaintiff verdicts in bellwether cases often push defendants toward settlement negotiations.

Pfizer has retained a large legal team and is expected to fight these claims aggressively. But the scientific evidence linking medroxyprogesterone acetate to meningioma is growing stronger with each new study published.

Depo Provera Lawsuit Payout

Depo-Provera lawsuit payouts will not be distributed until the litigation reaches a settlement or jury verdicts are issued. As of early 2026, no payouts have been made. But understanding the projected timeline for receiving money is important.

Here’s a realistic look at when claimants might see money:

These timelines are estimates based on how similar pharmaceutical MDLs have played out. The Zantac litigation took several years from MDL formation to settlement discussions. The talcum powder cases took even longer.

Several factors will determine how quickly payouts arrive:

• Bellwether trial results: Strong plaintiff wins speed things up
• Pfizer’s strategy: If they refuse to settle, the process takes longer
• Claim volume: More claims can slow down individual processing
• Your case strength: Well-documented cases may settle faster

Most attorneys handling Depo-Provera cases work on a contingency basis. That means your attorney takes a percentage (typically 33% to 40%) of your final payout. You don’t pay anything until money is awarded.

It’s a waiting game right now. But filing early positions you ahead of the curve. Claims filed later may face longer processing times once settlements begin.

Depo Shot Side Effects Lawsuit

The depo shot side effects lawsuit encompasses all claims related to injuries caused by Depo-Provera injections. While brain tumors are the primary focus of current litigation, the drug has a documented history of concerning side effects.

The FDA-approved label for Depo-Provera lists several known side effects:

• Bone density loss (osteoporosis risk)
• Weight gain
• Irregular menstrual bleeding or amenorrhea
• Headaches
• Depression and mood changes
• Decreased libido

But here’s the problem. Meningioma was not prominently featured in warnings provided to patients. The lawsuits allege this was a deliberate omission.

The legal theory is “failure to warn.” Pfizer had a duty to inform both doctors and patients about all known significant risks. If the company knew about the meningioma connection and didn’t adequately disclose it, that’s a breach of that duty.

The difference between a known side effect and an undisclosed risk is at the heart of these cases. Women accepted the known risks when they chose Depo-Provera. They were never given the chance to weigh the brain tumor risk.

That’s what makes these lawsuits different from general dissatisfaction with a drug. This is about hidden dangers.

Key Takeaway: The depo shot side effects lawsuit focuses specifically on the failure to warn about meningioma risk, a serious danger that was not properly disclosed to patients.

Depo Shot Brain Tumor Risk

The depo shot brain tumor risk is backed by growing scientific evidence. Research published between 2020 and 2024 has established a clear statistical link between prolonged medroxyprogesterone acetate use and increased meningioma incidence.

The most significant study came from French researchers affiliated with INSERM and CNRS. Their findings, published in 2024, analyzed health data from hundreds of thousands of women.

Key findings from the research:

• Women using injectable medroxyprogesterone acetate for over one year had a 5.6 times higher meningioma risk
• The risk increased with longer duration of use
• The elevated risk persisted even after women stopped receiving injections
• Meningiomas in these women were often progesterone-receptor positive, suggesting a hormonal mechanism

To understand what “5.6 times higher risk” means in practical terms: if the baseline risk of meningioma for women is roughly 1 in 10,000 per year, prolonged Depo-Provera use could push that to about 5.6 in 10,000.

That may sound small. But across the millions of women who’ve used this drug worldwide, it translates to thousands of potentially preventable brain tumors.

The biological mechanism makes intuitive sense. Meningioma cells frequently contain progesterone receptors. Flooding the body with synthetic progestin through quarterly injections essentially feeds any existing or developing meningioma cells.

Other studies, including research published in the BMJ (British Medical Journal), have corroborated these findings. The scientific consensus is moving firmly in the direction of plaintiffs.

Depo Provera Lawsuit Deadline 2026

The Depo-Provera lawsuit deadline varies by state, because each state sets its own statute of limitations for personal injury and product liability claims. There is no single national deadline.

Most states allow 2 to 3 years from the date of injury or the date of discovery to file a lawsuit. The “date of discovery” is when you learned (or reasonably should have learned) that your injury was connected to the drug.

The discovery rule is particularly relevant for Depo-Provera cases. Many women were diagnosed with meningioma years ago but only recently learned about the drug connection through news coverage or these lawsuits.

If you learned about the Depo-Provera/meningioma link in 2024 or 2025, your filing clock may have started then, not when you were diagnosed. This could mean you still have time in 2026 even if your diagnosis was years ago.

Don’t wait until the last minute. Attorneys need time to gather records, evaluate your claim, and prepare your filing. Starting the process 3 to 6 months before any potential deadline is smart practice.

If you’re unsure about your state’s deadline, a free consultation with a Depo-Provera attorney can clarify your situation quickly.

Depo Provera Lawsuit Evidence Needed

The evidence needed for a Depo-Provera lawsuit includes medical records proving both your use of the drug and your meningioma diagnosis. Without documentation, your claim will struggle to move forward.

Here’s a checklist of what you should start gathering now:

Explore this too: How Do You Qualify for a Zantac Lawsuit in 2026

Medical Records:

See also: Reed-Nelson Lawsuit 2026: Settlement and Payout Guide

• Pharmacy records showing Depo-Provera prescriptions filled
• Doctor visit notes documenting Depo-Provera injections received
• Dates of each injection (or as many as you can document)
• MRI or CT scan results showing meningioma
• Pathology reports from biopsy or surgery
• Surgical records if tumor was removed
• Post-operative and follow-up appointment records

Personal Documentation:

• A written timeline of your Depo-Provera use (start date, end date, frequency)
• Records of lost work days or reduced earning capacity
• Notes about symptoms and how they’ve affected daily life
• Receipts or insurance statements for medical costs

Your attorney will help with records retrieval. Medical facilities are required to provide your records upon request, though it can take 2 to 6 weeks.

The strongest cases have a clear paper trail. The more thoroughly you document your experience, the better positioned your claim will be.

Key Takeaway: Start gathering your medical records now, because well-documented claims are stronger claims, and retrieving records takes weeks.

Pfizer Depo Provera Lawsuit

Pfizer is the primary defendant in the Depo-Provera lawsuits. The pharmaceutical giant inherited the drug when it acquired Upjohn Company, which originally developed and marketed Depo-Provera.

Pfizer currently manufactures and sells Depo-Provera in the United States and globally. The company generates significant revenue from this product, as it remains one of the most widely prescribed injectable contraceptives.

The central allegation against Pfizer is failure to warn. Plaintiffs claim Pfizer:

• Had access to studies linking progestins to meningioma risk
• Failed to update the drug’s warning label to prominently disclose brain tumor risk
• Continued marketing the drug without adequate risk communication
• Prioritized revenue over patient safety

Pfizer’s likely defense strategy will center on several arguments:

• The risk was not conclusively proven at the time
• Warning labels included general information about potential side effects
• Individual plaintiff factors (genetics, other medications) contributed to tumor development
• Correlation does not equal causation

Pfizer has the resources to fight this litigation for years. The company has faced major lawsuits before, including Zoloft birth defect claims and Celebrex cardiovascular risk cases.

But the scientific evidence here is strong. And corporate internal documents expected to surface during discovery could reveal what Pfizer knew and when they knew it.

Depo Shot Cancer Risk

The depo shot cancer risk question extends beyond meningioma into other potential tumor types. While meningioma is the focus of current litigation, research has explored broader cancer connections to Depo-Provera use.

It’s important to distinguish between different types of risk:

Meningioma (Current Lawsuit Focus):
Meningiomas are technically not classified as “cancer” when they are Grade I (benign). However, they are brain tumors that require serious medical intervention. Grade II and Grade III meningiomas are considered atypical and malignant respectively.

Breast Cancer:
Some studies have shown a slight increase in breast cancer risk among current or recent Depo-Provera users. The FDA label does include a breast cancer warning.

Cervical Cancer:
Limited data has suggested a possible association, though evidence is less conclusive.

Interestingly, Depo-Provera has been associated with a decreased risk of endometrial cancer. So the drug’s effects on different tissues vary significantly.

The lawsuits in 2026 are focused squarely on meningioma. That’s where the science is strongest and where the failure-to-warn argument is most compelling.

If you’re concerned about other cancer risks from Depo-Provera, discuss your personal medical history with your doctor. But for legal purposes, meningioma is the injury driving this litigation.

Frequently Asked Questions

How much money can I get from a Depo-Provera lawsuit?

Estimated payouts range from $50,000 to $750,000 or more depending on injury severity.

Women who required brain surgery and suffered lasting disabilities are projected to receive the highest settlements.

No payouts have been distributed yet as of early 2026.

What is the deadline to file a Depo shots lawsuit in 2026?

The deadline depends on your state’s statute of limitations, typically 2 to 3 years from the date of discovery.

Many women still have time to file in 2026 because the Depo-Provera/meningioma link was only widely publicized in 2024.

Contact an attorney to confirm your specific deadline.

Does Depo-Provera really cause brain tumors?

Multiple peer-reviewed studies show a strong link between prolonged Depo-Provera use and meningioma brain tumors.

French researchers found the risk was 5.6 times higher in women who used injectable progestins for over one year.

The tumors often contain progesterone receptors, supporting a hormonal cause.

Is there a class action lawsuit for Depo-Provera?

No, the Depo-Provera litigation is an MDL (multidistrict litigation), not a class action.

Each plaintiff files an individual claim, and payouts are based on individual injuries rather than a shared pool.

This structure typically results in higher compensation for seriously injured claimants.

What evidence do I need to file a Depo-Provera claim?

You need medical records showing your Depo-Provera injections and a confirmed meningioma diagnosis.

MRI results, pathology reports, surgical records, and pharmacy records are the most important documents.

Your attorney can help you obtain these records from your healthcare providers.

The Depo-Provera lawsuit is moving forward in 2026 with real momentum. If you received these injections and developed a meningioma, now is the time to take action.

Gather your medical records. Contact an attorney who handles Depo-Provera cases. Find out if you qualify before filing deadlines pass.

Your health was put at risk without proper warning. The legal system offers a path to hold the responsible parties accountable and get the compensation you deserve.

Readers also liked: What Cancers Qualify for the Zantac Lawsuit in 2026?

A related guide: Essure Birth Control Lawsuit: Full 2026 Claim Guide

You may want to read James Henry Lawsuit 2026: Full Settlement and Claim Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.